ADVFN - Advanced Financial Network.
HOME» NASDAQ » T » TEVA Stock Price » TEVA Stock News

Teva Pharmaceutical Share News

 Teva Pharmaceutical Industries Limited (mm) Stock Price
TEVA Stock Price
 Teva Pharmaceutical Industries Limited (mm) Stock Chart
TEVA Stock Chart
 Teva Pharmaceutical Industries Limited (mm) Stock News
TEVA Stock News
 Teva Pharmaceutical Industries Limited (mm) Company Information
TEVA Company Information
 Teva Pharmaceutical Industries Limited (mm) Stock Trades
TEVA Stock Trades

Drug Maker Watson To Buy Actavis For About EUR4.5 Billion - Source

FRANKFURT -(Dow Jones)- U.S. generic drug maker Watson Pharmaceuticals Inc. (WPI) is close to buying rival Actavis valuing the Swiss-based company at about EUR4.5 billion, a person familiar with the matter told Dow Jones Newswires Wednesday. The deal could happen this month, although April is a more likely date, the person said. "The combination would be a good fit as Watson has a strong footprint in the U.S. and Actavis is well positioned in Europe," the person said. Spokesmen for Watson and Actavis declined to comment. Former Iceland-based Actavis is the world's fourth-largest generic drug maker in terms of sales behind Israel-based Teva Pharmaceutical Industries Ltd. (TEVA), Novartis AG's (NVS) unit Sandoz and U.S.-based Myland Inc. (MYL). Actavis increased its 2011 sales by 8% to about EUR1.84 billion, Chief Executive Claudio Albrecht told Dow Jones Newswires late January. "We are on track to achieve a top-line growth of 13% this year with profits climbing by 18%," he said. -By Eyk Henning, Dow Jones Newswires, 49-69-29725-108, eyk.henning@dowjones.com

Stock News for Teva Pharmaceutical (TEVA)
DateTimeHeadline
03/30/201508:14:08Teva to Acquire Auspex in $3.2 Billion Deal
03/23/201509:59:36Teva Migraine Therapy Shows Positive Results in Phase IIb Study
03/02/201509:50:38Correction to Story About Teva Selling Pennsylvania Facility
03/02/201509:18:27Teva Sells Pennsylvania Facility to G&W Laboratories
02/17/201508:33:57Teva to Distribute Eagle Pharmaceutical's Cancer Drug in U.S.
01/26/201508:10:04FDA Rejects Antares' Application for Generic Migraine Drug

Teva Pharmaceutical and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad